Sun, Xinghuai
Liu, Qinghuai
Tang, Xin
Yao, Ke
Li, Yan
Yang, Jin
Zhang, Mingchang
Yuan, Huiping
Zheng, Yan
Li, Weining
Peng, Huacong
Funding for this research was provided by:
Santen pharmaceutical (china) co., ltd
Article History
Received: 25 February 2022
Accepted: 22 July 2022
First Online: 5 August 2022
Declarations
:
: The study was conducted at 11 centers in China and was approved by the Ethics Committee of Eye and ENT Hospital, Shanghai Medical College, Fudan University (Approval No. 2017008–1).; the Ethics Committee of Beijing Tongren Hospital, Capital Medical University (Approval No. TREC2017-62); the Ethics Committee of The Second Affiliated Hospital, Harbin Medical University (Approval No. 2017-MD-023); the Ethics Committee of Tianjin Eye Hospital (Approval No. TJYYLL-2017–11); the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (Approval No. XHEC-C-2017–037-2); the Ethics Committee of First Affiliated Hospital of Kunming Medical University (Approval No. 2017-YL-29); the Ethics Committee of The First Affiliated Hospital of Nanjing Medical University (Approval No. 2017-MD-214); the Ethics Committee of Qilu Hospital, Shandong University (Approval No. 2017040); the Ethics Committee of Tongji Medical College, Union Hospital, Huazhong University of Science & Technology (Approval No. 2017–232); the Ethics Committee of The Second Affiliated Hospital, Zhejiang University School of Medicine (Approval No. 2017–430); the Ethics Committee of Wuhan Eyegood Ophthalmic Hospital (Approval No. AG-BNZ-201805). All methods were performed in accordance with the relevant guidelines and regulations. Informed consent was obtained from all subjects involved in the study.
: Not applicable.
: The authors declare that they have no competing interests.